These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 4398277)

  • 1. [In vitro studies on the mode of action and differences to heparin. Anticomplementary effect of a semisynthetic pentosan-polysulfo-ester].
    Walb D; Loos M; Hadding U
    Z Naturforsch B; 1971 May; 26(5):403-8. PubMed ID: 4398277
    [No Abstract]   [Full Text] [Related]  

  • 2. [Anticomplement actions of heparin-like and protamine-like substances].
    Timsit J; Giroud JP
    C R Seances Soc Biol Fil; 1976 Oct; 170(3):567-74. PubMed ID: 135617
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Anticomplementary activity of a polyanion: pentosan-poly-sulfoester, II.--Mode of action and "in vitro " inhibition of human complement hemolytic activity (author's transl)].
    Berthoux FX; Freyria AM; Traeger J
    Pathol Biol (Paris); 1977 Feb; 25(2):105-8. PubMed ID: 322041
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anticomplementary activity in unaggregated "purified" macroglobulin paraproteins.
    Glovsky MM; Fudenberg HH
    Immunochemistry; 1971 Feb; 8(2):129-40. PubMed ID: 4102100
    [No Abstract]   [Full Text] [Related]  

  • 5. Assay of anticomplementary activity in solutions of immunoglobulins.
    Römer J; Gardi A; Kistler P
    Dev Biol Stand; 1979; 44():147-51. PubMed ID: 544290
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Cl inactivator from guinea pig serum. 3. Characterization and kinetic data of the reaction between the inactivator and EACl and EACl4.
    Loos M; Wolf HU; Opferkuch W
    Immunochemistry; 1972 Apr; 9(4):451-9. PubMed ID: 4113723
    [No Abstract]   [Full Text] [Related]  

  • 7. [Anticomplementary activity of a polyanion: polyanion: pentosan-poly-sulfoester. I. "In vitro" study and "in vivo" trial in human glomerulonephritis (author's transl)].
    Berthoux FC; Freyria AM; Zech PY; Traeger J
    Pathol Biol (Paris); 1977 Jan; 25(1):33-6. PubMed ID: 322034
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunomodulatory action of propolis. V. Anticomplementary activity of a water-soluble derivative.
    Ivanovska ND; Dimov VB; Pavlova S; Bankova VS; Popov SS
    J Ethnopharmacol; 1995 Jul; 47(3):135-43. PubMed ID: 8569237
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of pentosan polysulphate and heparin. II: Effects of subcutaneous injection.
    Fischer AM; Merton RE; Marsh NA; Williams S; Gaffney PJ; Barrowcliffe TW; Thomas DP
    Thromb Haemost; 1982 Apr; 47(2):109-13. PubMed ID: 6179183
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction of plasma kallikrein with the C1 inhibitor.
    Gigli I; Mason JW; Colman RW; Austen KF
    J Immunol; 1970 Mar; 104(3):574-81. PubMed ID: 5435787
    [No Abstract]   [Full Text] [Related]  

  • 11. [Anticomplement activity of a polyanion: pentosan sulfuric polyester. III. Mechanism of functional inactivation of the different properdin and complement system fractions].
    Berthoux FC; Freyria AM; Traeger J
    Pathol Biol (Paris); 1977 Mar; 25(3):179-84. PubMed ID: 323787
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Natural inhibitors of complement. I. Anticomplementary activity associated with pokeweed mitogen (PWM).
    Gancevici GG; Popescu C
    Arch Roum Pathol Exp Microbiol; 1985; 44(4):337-46. PubMed ID: 3838045
    [No Abstract]   [Full Text] [Related]  

  • 13. [Relationship between anti-inflammatory and various sulfated polysaccharides endowed with anticoagulant properties].
    Giroud JP; Timsit J
    Therapie; 1973; 28(5):889-905. PubMed ID: 4794653
    [No Abstract]   [Full Text] [Related]  

  • 14. Anticomplementary activity of dextran derivatives.
    Mauzac M; Maillet F; Jozefonvicz J; Kazatchkine MD
    Biomaterials; 1985 Jan; 6(1):61-3. PubMed ID: 2578830
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibitory effects of omega-amino and omego-guanidino acid esters on the first component of human complement.
    Muramatu M; Shiraishi S; Fujii S
    Biochim Biophys Acta; 1972 Nov; 285(1):224-34. PubMed ID: 4675901
    [No Abstract]   [Full Text] [Related]  

  • 16. [Modification of proteolytic complement cascade after treatment with exogenous heparin].
    Galebskaia LV; Solovtsova IL; Riumina EV
    Vopr Med Khim; 2001; 47(1):91-7. PubMed ID: 11386002
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Characteristics of the action of an acidic sulfated polysaccharide on global blood coagulation in vitro. Preliminary study in various species of mammals and in man].
    Caporiccio B; Braun M; Vignaud M; Chalet M; Teste J; Codomier L; Catayée G
    C R Seances Soc Biol Fil; 1983; 177(4):412-20. PubMed ID: 6202380
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inactivation of C1 in rheumatoid synovial fluid, purfied C1 and C1 esterase, by gold compounds.
    Schultz DR; Volanakis JE; Arnold PI; Gottlieb NL; Sakai K; Stroud RM
    Clin Exp Immunol; 1974 Jul; 17(3):395-406. PubMed ID: 4219842
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new complement inhibitor in guinea pig serum.
    Okada H; Kawachi S; Nishioka K
    Jpn J Exp Med; 1969 Oct; 39(5):527-31. PubMed ID: 5309564
    [No Abstract]   [Full Text] [Related]  

  • 20. Irreversible enzyme inhibitors. 183. Proteolytic enzymes. 18. Inhibitors of guinea pig complement derived by quaternization of phenylalkylpyridines with -bromomethylbenzenesulfonyl fluorides.
    Baker BR; Doll MH
    J Med Chem; 1971 Sep; 14(9):793-9. PubMed ID: 5168671
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.